Cargando…
A scoping review of global vaccine certificate solutions for COVID-19
Globally, measures, such as lockdown, quarantining, and physical distancing, have been implemented to curb the spread of COVID-19. As the vaccines are now available and reintegration into society is beginning, measures such as vaccine certificates are being implemented around the world. We conducted...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920155/ https://www.ncbi.nlm.nih.gov/pubmed/34613869 http://dx.doi.org/10.1080/21645515.2021.1969849 |
_version_ | 1784669065920380928 |
---|---|
author | Mithani, Salima S. Bota, A. Brianne Zhu, David T. Wilson, Kumanan |
author_facet | Mithani, Salima S. Bota, A. Brianne Zhu, David T. Wilson, Kumanan |
author_sort | Mithani, Salima S. |
collection | PubMed |
description | Globally, measures, such as lockdown, quarantining, and physical distancing, have been implemented to curb the spread of COVID-19. As the vaccines are now available and reintegration into society is beginning, measures such as vaccine certificates are being implemented around the world. We conducted a scoping review to identify the initial digital solutions for COVID-19 vaccine certificates and evaluate them on the basis of purpose and use case, technological architecture, and ethical and legal implications. Articles identified from a Google search and a search of MEDLINE, Ovid and preprint servers were reviewed in duplicate, and data were extracted using a data extraction form. Data were extracted for date, location, type of article, source, companies identified for creating vaccine certificates, technology used, type of evidence provided (article quoting research study or an expert opinion), digital architecture, security and privacy measures, and use cases. Technology emerged as the most dominant theme followed by ethics, travel, legal concerns, public policy, and scientific concerns. Our review identified eight solutions that are working toward COVID-19 vaccine certificates world-wide, all optimizing blockchain technology. COVID-19 vaccine certificates are being considered in 11 countries and are in place in 5 others. Many issues concerning the themes we identified remain to be addressed to facilitate successful implementation. |
format | Online Article Text |
id | pubmed-8920155 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-89201552022-03-15 A scoping review of global vaccine certificate solutions for COVID-19 Mithani, Salima S. Bota, A. Brianne Zhu, David T. Wilson, Kumanan Hum Vaccin Immunother Coronavirus – Research Paper Globally, measures, such as lockdown, quarantining, and physical distancing, have been implemented to curb the spread of COVID-19. As the vaccines are now available and reintegration into society is beginning, measures such as vaccine certificates are being implemented around the world. We conducted a scoping review to identify the initial digital solutions for COVID-19 vaccine certificates and evaluate them on the basis of purpose and use case, technological architecture, and ethical and legal implications. Articles identified from a Google search and a search of MEDLINE, Ovid and preprint servers were reviewed in duplicate, and data were extracted using a data extraction form. Data were extracted for date, location, type of article, source, companies identified for creating vaccine certificates, technology used, type of evidence provided (article quoting research study or an expert opinion), digital architecture, security and privacy measures, and use cases. Technology emerged as the most dominant theme followed by ethics, travel, legal concerns, public policy, and scientific concerns. Our review identified eight solutions that are working toward COVID-19 vaccine certificates world-wide, all optimizing blockchain technology. COVID-19 vaccine certificates are being considered in 11 countries and are in place in 5 others. Many issues concerning the themes we identified remain to be addressed to facilitate successful implementation. Taylor & Francis 2021-10-06 /pmc/articles/PMC8920155/ /pubmed/34613869 http://dx.doi.org/10.1080/21645515.2021.1969849 Text en © 2021 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. |
spellingShingle | Coronavirus – Research Paper Mithani, Salima S. Bota, A. Brianne Zhu, David T. Wilson, Kumanan A scoping review of global vaccine certificate solutions for COVID-19 |
title | A scoping review of global vaccine certificate solutions for COVID-19 |
title_full | A scoping review of global vaccine certificate solutions for COVID-19 |
title_fullStr | A scoping review of global vaccine certificate solutions for COVID-19 |
title_full_unstemmed | A scoping review of global vaccine certificate solutions for COVID-19 |
title_short | A scoping review of global vaccine certificate solutions for COVID-19 |
title_sort | scoping review of global vaccine certificate solutions for covid-19 |
topic | Coronavirus – Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920155/ https://www.ncbi.nlm.nih.gov/pubmed/34613869 http://dx.doi.org/10.1080/21645515.2021.1969849 |
work_keys_str_mv | AT mithanisalimas ascopingreviewofglobalvaccinecertificatesolutionsforcovid19 AT botaabrianne ascopingreviewofglobalvaccinecertificatesolutionsforcovid19 AT zhudavidt ascopingreviewofglobalvaccinecertificatesolutionsforcovid19 AT wilsonkumanan ascopingreviewofglobalvaccinecertificatesolutionsforcovid19 AT mithanisalimas scopingreviewofglobalvaccinecertificatesolutionsforcovid19 AT botaabrianne scopingreviewofglobalvaccinecertificatesolutionsforcovid19 AT zhudavidt scopingreviewofglobalvaccinecertificatesolutionsforcovid19 AT wilsonkumanan scopingreviewofglobalvaccinecertificatesolutionsforcovid19 |